A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NFL / neurofilament light chain

[Related PubMed/MEDLINE]
Total Number of Papers: 219
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NFL  (>> Co-occurring Abbreviation)
Long Form:   neurofilament light chain
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A Systematic Review of the Use of Biochemical Markers in the Assessment of Spinal Cord Ischemia in Thoracoabdominal Aortic Aneurysm Repair. CSF, GFAP, S100B
2019 Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. IFN
2019 Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study. CSF, HC, ION, MS, OCBs, ON, ROC
2019 Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection. ART, CNS, CSF
2019 Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease. CSF, sCJD
2019 Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS. CSF, PMS
2019 Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial. CSF, RRMS, STRIX-MS
2019 CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. HAD
2019 Differential effects of neurodegeneration biomarkers on subclinical cognitive decline. ---
10  2019 Evaluation of Cerebrospinal Fluid Neurofilament Light Chain as a Routine Biomarker in a Memory Clinic. AUC, CSF
11  2019 HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection. Cho, CSF, FWM, mI, NAA, PCC
12  2019 Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease. CIS, CNS, CSF, IDD, MS, NC, NMOSD
13  2019 Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration. AD, CSF, MTG
14  2019 Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. ALS, CK, SBMA
15  2019 Neurofilament Light Chain as a Biomarker in Multiple Sclerosis. MS
16  2019 Neurofilament light chain as a biomarker in neurological disorders. CSF
17  2019 Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia. bvFTD
18  2019 Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis. pwMS
19  2019 Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. ALS, CJD
20  2019 Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study. HPW, P-MS, sNfL
21  2019 Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients. AD, DS
22  2019 Prognostic value of serum neurofilaments in patients with clinically isolated syndromes. CDMS, CIS, MS
23  2019 Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes. APS, CSF, DNER, PD, PEA
24  2019 Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis. CSF
25  2019 Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. ---
26  2019 Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest. IQR
27  2019 Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. ALS, UMN
28  2019 Serum Neurofilament light correlates with CADASIL disease severity and survival. GEE
29  2019 Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients. MS, PML
30  2019 Serum NFL discriminates Parkinson disease from atypical parkinsonisms. APDs, PD
31  2019 Vitamin D supplementation and neurofilament light chain in multiple sclerosis. MS, RRMS
32  2018 Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-beta Load and Cognitive Performance in Cognitively Normal Elderly Participants. AD, NAL, SMC
33  2018 Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis. AE, CSF, PGRN, t-tau
34  2018 Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination. APP, CSF, ELISA, GFAP
35  2018 Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls. CSF, ELISA, ELISA, Gal-1, MMSE, MS, PD
36  2018 Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. AD, AUC, CSF, DLB, FTD, p-tau, PNFA, ROC, sAPP, SD, t-tau
37  2018 Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis. CCI, CIS, CSF, MS, NBV, NCs, NGV, OPN, PGV, WMV
38  2018 Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis. APD, AUC, CBD, CSF, DOR, MSA, NLR, PD, PLR, PSP
39  2018 Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001. CSF, GFAP, LP, PD, pTau, STN-DBS, t-Tau
40  2018 Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. FTD, FTD-MND, FTLD, lvPPA, PPA
41  2018 Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain. CHI3L1, CSF, MS
42  2018 CSF beta-amyloid predicts prognosis in patients with multiple sclerosis. CI, CSF, EDSS, GM, MRI, MS, WM
43  2018 CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage. CSF, ELISA, MS
44  2018 CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. PSP, PSPRS, SEADL
45  2018 CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration. ALS, CSF, EDSS, PPMS
46  2018 CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers. FTD, p-tau, t-tau
47  2018 CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of Inflammation. CIS, CSF, HC, MS, PGRN, PPMS, RIS, RRMS
48  2018 Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6. AQP4-IgG, CSF, GFAP, IL, MS, NMOSD, OND, TGF, WBC
49  2018 Diagnostic and Prognostic Performance of Neurofilaments in ALS. ALS, pNF-H
50  2018 Diagnostic methods used in searching for markers of atrophy in patients with multiple sclerosis. CSF, MS
51  2018 Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI. AUC, CI, GFAP, mTBI
52  2018 High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome. CDMS, CIS, CSF, ELISA, HR, MRI, MS, OCB, SD
53  2018 Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia. ---
54  2018 Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes. CHI3L1, OCB
55  2018 Microbiome-Derived Lipopolysaccharide (LPS) Selectively Inhibits Neurofilament Light Chain (NF-L) Gene Expression in Human Neuronal-Glial (HNG) Cells in Primary Culture. AD, HNG, LPS, mRNA
56  2018 MicroRNA Signature of Traumatic Brain Injury: From the Biomarker Discovery to the Point-of-Care. C-tau, GFAP, MMTBI, mTBI, NSE, TBI, UCH-L1
57  2018 Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia. Abeta42, AD, p-tau
58  2018 Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis. CIS, CSF, RRMS
59  2018 Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy. CIPN
60  2018 Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy. cART, HAND
61  2018 Neurofilament light chain predicts disease activity in relapsing-remitting MS. CHI3L1, IFNB-1a, IQR, RRMS
62  2018 Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury. DOL, GA, IQR
63  2018 Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barre syndrome: A pilot study. CSF, GBS, GFAP, PCS, QoL
64  2018 Performance Evaluation of a Multiplex Assay for Simultaneous Detection of Four Clinically Relevant Traumatic Brain Injury Biomarkers. CT, GFAP, TBI, UCH-L1
65  2018 Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment. ART, CSF, PLHIV
66  2018 Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia. FRDA, GFAP, t-tau, UCHL1
67  2018 Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease. AD, CSF, MCI-AD, MMSE
68  2018 Plasma neurofilament light chain concentration in the inherited peripheral neuropathies. CMT
69  2018 Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod. CSF, MS, SD
70  2018 Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers. CSF
71  2018 Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis. CHI3L1, CIS, CSF, EDSS, RRMS
72  2018 Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients. CSF, HD
73  2018 Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies. CIDP, CSF, MAG, PN
74  2018 Serum GFAP as a biomarker for disease severity in multiple sclerosis. CSF, EDSS, GFAP, MS, OND, PMS, RRMS
75  2018 Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity. CNS, CSF, EDSS, GFAP, MRI, MS
76  2018 Serum neurofilament light chain in behavioral variant frontotemporal dementia. AD, bvFTD, CDR-SOB, CON, MCI, MMSE
77  2018 Serum neurofilament light chain in progressive supranuclear palsy. PSP
78  2018 Serum neurofilament light chain is increased in hereditary spastic paraplegias. HSPs
79  2018 Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden. CADASIL, MRI, mRS, NIHSS, SVD
80  2018 Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke. IS
81  2018 Significance of CSF NfL and tau in ALS. ALS, CSF, CST, FA, t-tau
82  2018 TDP-43 and Cytoskeletal Proteins in ALS. ALS, MAP1B, pNF-H, TAR
83  2018 Valproic Acid Treatment Decreases Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels in Swine Subjected to Traumatic Brain Injury. AUC0-10days, CCI-TBI, GFAP, NS, VPA
84  2018 YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression. ALS, ELISA, SALS
85  2017 Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. APD, AUC, CBS, MSA, PD, PSP
86  2017 Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy. BBB, cART, CSF, HIV, QAlb
87  2017 Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatricdisorders. Abeta1-42, AUC, bvFTD, CI, CSF, p-tau, PSY, tau
88  2017 Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis. CHI3L1, CSF, RRMS
89  2017 Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review. PD
90  2017 Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis. CHI3L1, CSF, DMTs, ELISA, GFAP, NGRN, RRMS
91  2017 Cerebrospinal Fluid Biomarkers of Neurodegeneration Are Decreased or Normal in Narcolepsy. CHI3L1, CSF, T-tau
92  2017 Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals. cART, CSF, ELISA, HANDs, IFN-alpha
93  2017 Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis. CSF, IL-1beta, MS, PBVC
94  2017 Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis. CSF, MSA, p-tau, PD, Std. MD
95  2017 Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis. ---
96  2017 Defining active progressive multiple sclerosis. CHI3L1, CSF, MBP, MMP-9, MS
97  2017 Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease. AD, CSF, FTD, HCs, MCI
98  2017 Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease. ALS, FTD, HR
99  2017 Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net. ECAS, PGRN
100  2017 Fluid biomarker and electrophysiological outcome measures for progressive MS trials. CSF, EPs, MRI, MS